Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
August 29, 2019
New Momentum Magnetic Particle Imaging Scanner to be Installed in Baltimore
August 27, 2019
Arvinas Announces the Initiation of Patient Dosing in a First-In-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTAC® Protein Degrader
August 21, 2019
Scientist.com Named to Inc. 500 List for Third Consecutive Year With Three-Year Revenue Growth of 1,522%
August 21, 2019
Cidara Therapeutics to Present Data From its Cloudbreak Antiviral Program at the Options X for the Control of Influenza Conference
August 7, 2019
Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer
August 6, 2019
Cleave Therapeutics Appoints Amy Burroughs Chief Executive Officer and Completes $12 Million Equity Financing
August 5, 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
July 31, 2019
Vor Biopharma Appoints Dr. Bill Lundberg to its Board of Directors
July 29, 2019
Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer
July 29, 2019
Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin
« Previous Page
1
…
4
5
6
7
8
…
12
Next Page »